Skip to content
Study details
Enrolling now

Ultrasonic Neuromodulation of Cingulate Cortex for Fibromyalgia

SPIRE Therapeutics Inc.
NCT IDNCT07226648ClinicalTrials.gov data as of Apr 2026
Target enrollment

180

Study length

about 1.1 years

Ages

22+

Locations

4 sites in MN, NY, UT +1

What this study is about

This trial is testing a new noninvasive brain stimulation intervention called focused ultrasound to see if it can reduce pain in people with fibromyalgia. Participants will receive four treatments over one month and complete surveys at different points during the 16-week trial.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Use Focused Ultrasound

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
Randomized & Blinded

You may get a placebo/standard care, and you won't know which.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Primary: Numerical Rating Scale - 11 (NRS-11) pain score

Secondary: Numerical Rating Scale - 11 (NRS-11) pain score, Numerical Rating Scale - 11 (NRS-11) pain score response rate, Patient Global Impression of Improvement (PGI-I), Patient Health Questionnaire-9 (PHQ-9), Patient-Reported Outcomes Measurement Information System (PROMIS-29) - Pain Interference Subscale

Body systems

Musculoskeletal